Results 41 to 50 of about 7,915 (234)

Bounding the First Zagreb Index of a Tree in Term of Its Repetition Number [PDF]

, 2023
Lin Hong, Jianguo Qian
openalex   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Extremal values on Zagreb indices of trees with given distance k-domination number

Journal of Inequalities and Applications, 2018
Let G = ( V ( G ) , E ( G ) ) $G=(V(G),E(G))$ be a graph. A set D ⊆ V ( G ) $D\subseteq V(G)$ is a distance k-dominating set of G if for every vertex u ∈ V ( G ) ∖ D $u\in V(G)\setminus D$ , d G ( u , v ) ≤ k $d_{G}(u,v)\leq k$ for some vertex v ∈ D $v ...
Lidan Pei, Xiangfeng Pan
doaj   +1 more source

First General Zagreb Co‐Index of Graphs under Operations [PDF]

, 2022
Muhammad Javaid, Muhammad Ibraheem, Ebenezer Bonyah, Uzma Ahmad, Shaohui Wang   +4 more
openalex   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

The Topological Indices of Coprime Graph for Integer Module Group

Jurnal Diferensial
This study delves into the fascinating realm of coprime graphs within the integer modulo group, revealing a fundamental property where these graphs manifest as star graphs when the order corresponds to a prime power.
Abdurahim Abdurahim, Zata Yumni Awanis, Bulqis Nebulla Syechah, Syaharuddin Syaharuddin   +3 more
doaj   +1 more source

The modified first Zagreb connection index and the trees with given order and size of matchings [PDF]

, 2021
Sadia Noureen, Bhatti Ahmad
openalex   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source